Trial Profile
A Phase II Study of Valproic Acid in Combination With FEC100 for Primary Therapy in Patients With Locally Advanced or Primary Metastatic Breast Cancer.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Valproic acid (Primary) ; Cyclophosphamide; Epirubicin; Fluorouracil
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 24 Feb 2011 Additional lead trial investigator identified as reported by ClinicalTrials.gov.
- 24 Feb 2011 Additional lead trial investigator identified as reported by ClinicalTrials.gov.
- 17 Nov 2009 New trial record